Invivogen
Menu

IL-9 Reporter HEK 293 Cells

HEK-Blue™ IL-9 Cells Unit size Cat. code Docs Qty Price
HEK 293 reporter cells for human and murine IL-9 cytokines
3-7 x 10e6 cells
hkb-il9
+-
$1,304.00

You may also need : QUANTI-Blue™ | View more associated products

HEK-Blue™ IL-9 Cells signaling pathway
HEK-Blue™ IL-9 Cells signaling pathway

Interleukin-9 Reporter Cells

HEK-Blue™ IL-9 cells were engineered from the human embryonic kidney HEK 293 cell line to detect bioactive interleukin-9 (IL-9) by monitoring the activation of the JAK/STAT5 pathway.  Originally identified as a growth factor of T cells and mast cells, IL-9 is now regarded as a multifunctional cytokine that regulates the function of many different cell types and plays an important role in immunity and immune pathogenesis [1-3].

More details More details

 

Cell line description:

HEK-Blue™ IL-9 cells were generated by stable overexpression of the genes encoding the alpha chain of human IL-9 receptor (IL-9Rα), human IL-2Rγ, human JAK3, human STAT5b, and a STAT5-inducible secreted embryonic alkaline phosphatase (SEAP) reporter. STAT5-dependent SEAP activity is readily assessable in the supernatant using QUANTI-Blue™ Solution, a detection reagent.  Of note, HEK-Blue™ IL-9 cells also respond to human type II interferons (IFN-γ; see Figures). However, they do not respond to human type I IFNs (IFN-α/IFN-β), as they are knock-out for IFNAR2.

Features of HEK-Blue™ IL-9 cells:

  • Fully functional IL-9 signaling pathway
  • Readily assessable STAT5-inducible SEAP reporter activity
  • The stability for 20 passages has been verified
  • Functionally tested and guaranteed mycoplasma-free

Applications of HEK-Blue™ IL-9 cells:

  • Detection of human IL-9 (100 pg/ml - 100 ng/ml) and murine IL-9 (30 pg/ml -100 ng/ml)
  • Screening of anti-IL-9 and anti-IL-9R antibodies

 

References:

1. Ritobrata G. & Kaplan M.H., 2011. A brief history of IL-9. J Immunol. 186(6):3283-8.
2. Chakraborty S. et al., 2019. An update on interleukin-9: From its cellular source and signal transduction to its role in immunopathogenesis. Int J Mol Sci. 20(9):2113.
3. Patrussi L. et al., 2021. Interleukin (IL)-9 supports the tumor-promoting environment of chronic lymphocytic leukemia. Cancers (Basel). 13(24):6301.

Figures

Validation of IL-9Rα expression
Validation of IL-9Rα expression

Validation of the expression of human IL-9Rα by HEK-Blue™ IL-9 cells.
5 x 105 cells were incubated with either a PE-conjugated isotype control (blue) or a PE-conjugated Anti-IL-9Rα mAb (red) for 30 minutes. The binding affinity was then measured using flow cytometry.

Cellular response to IL-9
Cellular response to IL-9

Dose-response of HEK-Blue™ IL-9 cells to recombinant IL-9.
Cells were stimulated with increasing concentrations of recombinant human IL-9 (hIL-9) and murine IL-9 (mIL-9). After overnight incubation, the STAT5 response was determined using QUANTI‑Blue™ Solution, a SEAP detection reagent. The optical density (OD) at 630 nm is shown as mean ± SEM.

IL-9 signaling inhibition
IL-9 signaling inhibition

Dose-dependent inhibition of HEK‑Blue™ IL-9 cellular response using a neutralizing antibody against hIL-9.
The antibody was incubated with hIL-9 (0.3 ng/ml) for 2 hours prior to the addition of HEK-Blue™ IL-9 cells. After overnight incubation, SEAP activity in the cell culture supernatant was assessed using QUANTI-Blue™ Solution. Data are shown as a percentage (%) of activity.

Cell line specificity of HEK-Blue™ IL-9 cells
Cell line specificity of HEK-Blue™ IL-9 cells

Response of HEK-Blue™ IL-9 cells to a panel of cytokines.
Cells were stimulated with various human and murine recombinant cytokines: 1 ng/ml of hIL-9 or mIL-9, and 100 ng/ml hIL-2, hIL-4, hIL‑6, hIL-7, mIL-7, hIL‑15, hIL-21, or hIL-27, and 1000 U/ml hIFN-α, and 10 ng/ml hIFN-γ. After overnight incubation, SEAP activity was assessed using QUANTI‑Blue™ Solution. The optical density (OD) at 630 nm is shown as mean ± SEM.

Back to the top

Specifications

Antibiotic resistance: Blasticidin, Hygromycin, PuromycinZeocin®

Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™

Guaranteed mycoplasma-free

Specificity: human and murine IL-9

Detects human and murine IL-9

  • Detection range for human IL-9: 100 pg - 100 ng/ml
  • Detection range for murine IL-9: 30 pg - 100 ng/ml

 

This product is covered by a Limited Use License (See Terms and Conditions).

Back to the top

Contents

Dry ice shipping Shipped on dry ice (Europe, USA, Canada and some areas in Asia)

Back to the top

Details

Interleukin 9 (IL-9) is a secreted cytokine produced primarily by T helper 2 (Th2) cells. It supports the growth of activated T cell subsets and promotes mast cell proliferation and differentiation [1, 2]. In addition, IL-9 has a direct effect on epithelial cell function stimulating the production of mucin and T cell chemoattractants [2, 3].
IL-9 signals through the heterodimeric cell surface IL-9 receptor (IL-9R) consisting of IL-9Rα (also called CD129) and IL-2Rγ (also called the common γ-chain or CD132). The binding of IL-9 to its receptor triggers three main signaling pathways: JAK/STAT, MAPK, and PI3K [1, 2]. IL-9 is an interesting therapeutic target as it plays a critical role in immunity to parasitic infections, the pathogenesis of cancer and immuno-pathological conditions such as asthma [5, 6].  

 

1. Ritobrata G. & Kaplan M.H., 2011. A brief history of IL-9. J Immunol. 186(6):3283-8.
2. Chakraborty S. et al., 2019. An update on interleukin-9: From its cellular source and signal transduction to its role in immunopathogenesis. Int J Mol Sci. 20(9):2113.
3. Longphre M. et al., 1999. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest . 104(10):1375-82.
4. Little F.F. et al., 2001. Il-9 stimulates release of chemotactic factors from human bronchial epithelial cells.Am J Respir Cell Mol Biol . 25(3):347-52.
5. Silva N.S.L. et al., 2021. Interleukin-9 in immunopathology of Trypanosoma cruzi experimental infection. Front Cell Infect Microbiol. 11:756521. 
6. Patrussi L. et al., 2021. Interleukin (IL)-9 supports the tumor-promoting environment of chronic lymphocytic leukemia. Cancers (Basel). 13(24):6301.

Back to the top

FAQ Cell Lines

Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top
Customer Service
& Technical Support
Shopping cart is empty